Results 31 to 40 of about 1,084 (183)
Conjunctival Myxoma: Series of Three Cases of a Rare Ocular Tumour [PDF]
Journal of Clinical and Diagnostic Research, 2022 Conjunctival myxomas are very rare benign tumours of mesenchymal origin which pose a diagnostic challenge clinically and radiologically. They usually present as asymptomatic slowly growing cystic lesions involving the bulbar conjunctiva.
Yasmeen Khatib +4 more
doaj +1 more source
Laryngoscope Investigative Otolaryngology, Volume 7, Issue 4, Page 1155-1163, August 2022., 2022 Expression of D amino acid in congenital and aquired cholesteatoma. Abstract Objective/Hypothesis Middle ear cholesteatoma is characterized by abnormal growth of the keratinizing squamous epithelium of the temporal bone. d‐β‐aspartic acid is the major isomer of d‐aspartic acid found in elderly tissue.
Shiori Kitaya +12 more
wiley +1 more source
JIMD Reports, Volume 63, Issue 4, Page 351-360, July 2022., 2022 Abstract Homogentisic acid (HGA) lowering, disease modifying off‐label nitisinone therapy has been used in the United Kingdom National Alkaptonuria Centre (NAC) since 2012. This study evaluated the serendipitous observation of cataract in a large cohort of patients with the very rare disease alkaptonuria (AKU), over a 5‐year period.
Mohammad S. Z. Ahmad +6 more
wiley +1 more source
The prevalence of dry eye in a very old population
Acta Ophthalmologica, Volume 100, Issue 3, Page 262-268, May 2022., 2022 Abstract Purpose To assess the prevalence of dry eye disease (DED) and Meibomian gland dysfunction (MGD) in a very old population. Methods The Ural Very Old Study (UVOS), a population‐based cohort study performed in rural and urban Bashkortostan/Russia, included 1526 (81.1%) out of 1882 eligible individuals aged 85+ years.
Mukharram M. Bikbov +16 more
wiley +1 more source
Journal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022 Purpose. Dry eye disease (DED) can be triggered using preserved ophthalmic formulations or prostaglandin analogs. In this prospective, nonrandomized, open‐label pilot study, we evaluated the efficacy of a 0.15% hyaluronic acid (HA) nonpreserved ophthalmic formulation in decreasing DED symptoms in patients with open‐angle glaucoma treated with ...
Giulia Coco +5 more
wiley +1 more source
International Journal of Telemedicine and Applications, Volume 2022, Issue 1, 2022., 2022 Objective. To describe the clinical indications and the impact of implementation of specific teleophthalmology referral guidelines in a large rural village vision centre network in India. Methods. This cross‐sectional vision centre‐based study included 1,016,284 patients presenting between January 2017 and March 2020.
Anthony Vipin Das +4 more
wiley +1 more source
Survey of Ophthalmology, 1988 Pingueculae and pterygia are benign peribulbar lesions composed of degenerated basophilic subepithelial tissue. Pingueculae do not affect vision, and minor irritation can usually be managed with artificial tears. Pterygia may affect the visual axis and require surgical and adjunctive treatment. The various therapeutic strategies are reviewed.
P A, Jaros, V P, DeLuise
openaire +2 more sources
Prevalence of pinguecula and pterygium in a general population in Spain [PDF]
, 2010 PURPOSE: To determine the prevalence of pinguecula and pterygium and to investigate their associations in a general adult population in North-Western Spain.
E Viso +5 more
core +2 more sources
To Study the Effect of Mahaoushadhadi Anjana in the Management of Pishtak with special reference to Pinguecula [PDF]
, 2022 Bindu (dot/spot) which is bulged up resembling water, white like flour of rice and round in shape is known as Pistaka. Acharya Sushruta is described Pistaka is Ashastrakruta vyadhi in Sushruta uttartantra 8 chapter 9 sholka.
Santosh Kumar Sahu +1 more
core +1 more source
Evidence-Based Complementary and Alternative Medicine, Volume 2021, Issue 1, 2021., 2021 Background. Sedum dendroideum has antioxidant effects that are beneficial for different diseases. We aimed to analyze the antiproliferative activity of S. dendroideum in human pterygium fibroblasts (HPFs). Methods. HPFs were treated for 24 h with 0–1000 μg/mL of S.
Paloma López-Montemayor +10 more
wiley +1 more source